Newsletter

FDA approves the use of the Moderna vaccine among Thai adolescents aged 12-17 years

In case the FDA approved the use of the vaccine, Moderna on Sept. 16, ’64 ZP Therapeutics, a business unit under Zillic Pharma, a service provider Leading healthcare in Asia Revealed that the Food and Drug Administration (FDA) has increased approval for the use of the Covid-19 vaccine in Thailand among teenagers aged 12-17 years old, with the same vaccination pattern as the injection. The adult group is vaccinated with 2 doses, with the second injection 28 days after the first dose.

Mrs. Sunaina Kitkasetpaisan General Manager, ZP Therapy, Zillic Pharma Thailand, said the approval of the COVID-19 vaccine for adolescents It is considered to increase the potential of the COVID-19 vaccine. that Thailand can use to combat the epidemic situation. The company is very pleased that the Food and Drug Administration has approved the use of the Covid-19 vaccine “Moderna” for teenagers. in order to have a shield against COVID-19 Especially in situations where the delta strain continues to spread heavily.

“We are working hard to support Thailand’s vaccination plan. How much can we support vaccination to cover people? The faster the group immunity will be driven. And it will also help the country return to normal faster in the end. We are extremely proud to be a part of this important mission.”

In May, Moderna announced the results of a Phase 2/3 clinical study of the Covid-19 Moderna vaccine in adolescents (Phase 2/3 TeenCOVE study). EARN SUCCESS IN IMMUNITY Equivalent to vaccine immunization among adults

Two doses of the COVID-19 Moderna vaccine have been shown to be 100% effective in preventing symptomatic infection among adolescents aged 12-17 years, and are effective in terms of safety and response. The results of a Phase 3 clinical trial in adults (Phase 3 COVE study) were observed in Moderna. and continues to monitor research results from independent safety monitoring committees. These data are subject to change depending on the results of additional data collection.

However, Moderna will be the second brand of vaccine approved for children and adolescents in Thailand after Pfizer, which on September 14 at the Government House, Deputy Prime Minister and Minister Anutin Charnvirakul. public health Discussing plans for vaccination against COVID-19 For those aged 12 years and over that the goal of providing vaccines for children is In order to be safe from the epidemic, it is planned that the service will be delivered to the school. Vaccines to be provided Initially, only the Pfizer vaccine was available. Because it is the only brand registered with the Food and Drug Administration (FDA) states that it can be injected in people aged 12 years and over.

Related news

– Zillic informs the delivery of the Moderna vaccine to Thailand in the middle of October. Send more than 3 hundred thousand doses per week
– The Cabinet approved a central budget of 946 million for the Red Cross to buy 1 million doses of the Moderna vaccine, injecting vulnerable groups for free.
– Chulabhorn Royal College signed a contract to import 8 million doses of Moderna to use as a stimulant next year.

.